Skip to main content
BioMaxima S.A. logo

BioMaxima S.A. — Investor Relations & Filings

Ticker · BMX ISIN · PLBIOMX00015 LEI · 2594007GAALFMXP4YB89 WAR Manufacturing
Open in API
Filings indexed 617 across all filing types
Latest filing 2022-09-29 Director's Dealing
Country PL Poland
Listing WAR BMX

About BioMaxima S.A.

https://www.biomaxima.com/

BioMaxima S.A. is a manufacturer specializing in in-vitro diagnostics. The company's primary activities include the development and production of a wide range of products for laboratory diagnostics, with a focus on clinical microbiology. Key product categories include microbiological media, various diagnostic reagents, and specialized laboratory equipment. In addition to its manufacturing operations, BioMaxima also serves as a distributor for products from other global diagnostics firms. The company is actively involved in product innovation, including the development of Minimum Inhibitory Concentration (MIC) tests for antibiotic susceptibility testing.

Recent filings

Filing Released Lang Actions
Zestawienie transakcji
Director's Dealing Classification · 98% confidence The document text consists of tables titled "Zestawienie transakcji" (Transaction Summary) detailing trades with columns for quantity, price, value, and dates. This structure strongly suggests a report detailing personal share transactions by executives or directors, which falls under the definition of Director's Dealing (DIRS). It is not a comprehensive annual report (10-K), an earnings release (ER), or a general regulatory filing (RNS), but a specific disclosure of insider trading activity. Checking the definitions: - DIRS: Report of personal share transactions by company directors and executives (insider trades). This matches the content perfectly.
2022-09-29 English
Nabycie akcji własnych - Content (PL)
Transaction in Own Shares Classification · 98% confidence The document text, written in Polish, details the acquisition of the company's own shares (akcji własnych) by the Issuer (Emitent) over specific dates (26.09.2022 to 28.09.2022). It specifies the number of shares bought, the average price, and the resulting percentage of the share capital and voting rights. This activity directly corresponds to a share repurchase program. The definition for 'Transaction in Own Shares' (Code: POS) is 'Report of the company buying back or selling its own shares (share repurchase/issuance)'. The document is a detailed report of these transactions, not just an announcement of a future report. Therefore, POS is the most appropriate classification.
2022-09-29 Polish
Zestawienie transakcji
Director's Dealing Classification · 85% confidence The document text consists entirely of tabular data showing transaction records, including codes (KOD_PW), quantities (IL_ZREA), prices (KURS), total values (WARTOSC), and dates (DATA_NOTY, DATA_ROZL). The presence of columns like 'KURS' (Price) and 'WARTOSC' (Value) strongly suggests trading activity. The code 'PLBIOMX00015' appears consistently, likely identifying the security. This structure is characteristic of regulatory filings related to insider trading or significant share transactions. Comparing the definitions, 'Director's Dealing' (DIRS) covers personal share transactions by directors, and 'Transaction in Own Shares' (POS) covers company buybacks/sales. Since this data appears to be a log of market transactions rather than a formal declaration of a director's personal trade or a formal announcement of a company repurchase program, and given the highly specific, raw data format, it most closely aligns with insider transaction reporting, which falls under DIRS if it relates to executives, or potentially a specialized regulatory filing (RNS) if it's a general market notification. However, the data structure strongly resembles transaction reports often associated with insider activity or major shareholding changes. Given the options, and assuming this is a report detailing transactions that might involve insiders or significant holders, 'Director's Dealing' (DIRS) is a plausible fit if the context implies executive trades, or 'Major Shareholding Notification' (MRQ) if the quantities represent crossing thresholds. Since the data is raw transaction logs without explicit context linking it to a director or a specific threshold crossing announcement, and it doesn't fit the standard financial report formats (10-K, IR, ER), the most appropriate category for detailed transaction reporting that isn't a formal company action (POS) is often related to insider activity (DIRS) or a general regulatory filing (RNS). Given the nature of the data (price/volume logs), it is highly likely related to share ownership changes. If this data represents the *result* of insider trading disclosures, DIRS is appropriate. If it's a general market notification of trades, RNS is the fallback. Without explicit context, DIRS is often used for detailed transaction logs related to individuals. However, looking closely at the data, it seems to be market data (order book/trade log) rather than a formal DIRS filing document. Since it is raw, structured data that doesn't fit the primary financial reports, and it's not a simple announcement (RPA), the best fit among the specific options for detailed transaction reporting is DIRS (Director's Dealing) or MRQ (Major Shareholding Notification). Since the data is granular transaction data, it is less likely to be a formal MRQ announcement and more likely related to insider activity reporting, even if the source is raw. I will classify it as DIRS based on the transaction nature, but acknowledge RNS as a strong secondary possibility if this is a general market data feed.
2022-09-23 English
Nabycie akcji własnych - Content (PL)
Transaction in Own Shares Classification · 99% confidence The document text, written in Polish, details the daily acquisition of the company's own shares (akcji własnych) by the Issuer (Emitent) between September 19 and September 23, 2022. It specifies the number of shares bought, the average price, and the resulting percentage of the share capital. This activity directly corresponds to a share repurchase program. The filing category 'Transaction in Own Shares' (Code: POS) is the most appropriate classification for reporting the execution of a share buyback program.
2022-09-23 Polish
Podpisanie znaczącej umowy - Content (PL)
Regulatory Filings Classification · 95% confidence The document text is very short (519 characters) and describes a significant contract signed by the management board ('Zarząd BioMaxima S.A. informuje'). The contract involves the sale and delivery of a cell culture analyzer for 990,450.00 PLN, which is deemed 'istotna' (material) to the company's core business. This is a specific announcement regarding a material contract or transaction that impacts the company's operations and revenue outlook, but it does not fit neatly into standard financial reports (10-K, IR), management changes (MANG), or dividend notices (DIV). Given the nature of reporting material contracts, it is best classified as a general Regulatory Filing (RNS), as it is a material event disclosure that doesn't match the more specific categories like M&A (TAR) or Financing (CAP).
2022-09-19 Polish
Zestawienie transakcji
Transaction in Own Shares Classification · 98% confidence The document text consists almost entirely of tabular data showing transaction records, including codes (KOD_PW), quantities (IL_ZREA), price (KURS), value (WARTOSC), and dates (DATA_NOTY, DATA_ROZL). This structure strongly suggests a report detailing transactions in the company's own shares, which aligns with the definition of 'Transaction in Own Shares' (POS). It is not a comprehensive financial report (10-K, IR), an earnings release (ER), or a management discussion (MDA). It is a specific regulatory disclosure about share movements.
2022-09-16 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.